Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dihydropyrimidine Dehydrogenase Polymorphism c.2194G>A Screening Is a Useful Tool for Decreasing Gastrointestinal and Hematological Adverse Drug Reaction Risk in Fluoropyrimidine-Treated Patients. | Curr Issues Mol Biol | 2024 | 39329936 | PubTator, text mining | PubMed |
| 5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1). | J Hepatobiliary Pancreat Sci | 2024 | 39318258 | PubTator, text mining | PubMed |
| Metabolic reprogramming of hypoxic tumor-associated macrophages through CSF-1R targeting favors treatment efficiency in colorectal cancers. | J Immunother Cancer | 2024 | 39317456 | PubTator, text mining | PubMed |
| Identification of diagnostic markers and molecular clusters of cuproptosis-related genes in alcohol-related liver disease based on machine learning and experimental validation. | Heliyon | 2024 | 39315155 | PubTator, text mining | PubMed |
| Evaluation of chemotherapy toxicities in patients receiving treatment for gastrointestinal cancers and therapeutic monitoring of 5-fluorouracil as a clinical support tool. | Fundam Clin Pharmacol | 2024 | 39304990 | PubTator, text mining | PubMed |
| Schizophrenia risk-associated SNPs affect expression of microRNA 137 host gene: a postmortem study. | Hum Mol Genet | 2024 | 39239979 | PubTator, text mining | PubMed |
| Patterns of pharmacogenetic variation in nine biogeographic groups. | Clin Transl Sci | 2024 | 39206687 | PubTator, text mining | PubMed |
| Reply to "A call for reporting of tumor-specific outcomes in studies of DPYD genotyping". | Clin Transl Sci | 2024 | 39172770 | PubTator, text mining | PubMed |
| The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer. | Cancer Med | 2024 | 39158384 | PubTator, text mining | PubMed |
| Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities. | Gut Microbes | 2024 | 39150897 | PubTator, text mining | PubMed |
| A call for reporting of tumor-specific outcomes in studies of DPYD genotyping. | Clin Transl Sci | 2024 | 39148268 | PubTator, text mining | PubMed |
| Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD. | Genome Med | 2024 | 39148102 | PubTator, text mining | PubMed |
| Optimizing cancer patient care with a robust assay for 5-fluorouracil quantification and in-vitro stability in human blood for therapeutic drug monitoring. | Pract Lab Med | 2024 | 39132451 | PubTator, text mining | PubMed |
| MIR27A Gene Polymorphism Modifies the Effect of Common DPYD Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy. | Int J Mol Sci | 2024 | 39126072 | PubTator, text mining | PubMed |
| Editorial: State of the science of pharmacogenomics implementation in healthcare systems and communities. | Front Pharmacol | 2024 | 39114360 | PubTator, text mining | PubMed |
| Clinical Implementation of Rare and Novel DPYD Variants for Personalizing Fluoropyrimidine Treatment: Challenges and Opportunities. | Int J Biol Sci | 2024 | 39113696 | PubTator, text mining | PubMed |
| Fluoropyrimidine Toxicities and DPYD Genotyping: A Clinical Case. | Cureus | 2024 | 39099950 | PubTator, text mining | PubMed |
| Partial protein binding of uracil and thymine affects accurate dihydropyrimidine dehydrogenase (DPD) phenotyping. | J Pharm Biomed Anal | 2024 | 39067280 | PubTator, text mining | PubMed |
| Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study. | Pharmaceutics | 2024 | 39065653 | PubTator, text mining | PubMed |
| Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (DPYD). | Int J Mol Sci | 2024 | 39062841 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=13